Art

J-GLOBAL ID：201702291092565307   Reference number：17A1371034

Effect of Infectious Diseases on the Pathogenesis of Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis

Stevens-Johnson症候群および中毒性表皮壊死症の病態形成に対する感染性疾患の影響

Author (7)： Okamoto-Uchida Yoshimi (Division of Medicinal Safety Science, National Institute of Health Sciences) ,  Nakamura Ryosuke (Division of Medicinal Safety Science, National Institute of Health Sciences) ,  Sai Kimie (Division of Medicinal Safety Science, National Institute of Health Sciences) ,  Imatoh Takuya (Division of Medicinal Safety Science, National Institute of Health Sciences) ,  Matsunaga Kayoko (Department of Integrative Medical Science for Allergic Disease, School of Medicine, Fujita Health University) ,  Aihara Michiko (Department of Environmental Immuno-Dermatology, Graduate School of Medicine, Yokohama City University) ,  Saito Yoshiro (Division of Medicinal Safety Science, National Institute of Health Sciences)
Material： Biological and Pharmaceutical Bulletin  (Biological & Pharmaceutical Bulletin)
Volume： 40  Issue： 9  Page： 1576-1580(J-STAGE)  Publication year： 2017 
JST Material Number： S0989A  ISSN： 0918-6158  CODEN： BPBLEO  Document type： Article
Article type： 原著論文  Country of issue： Japan (JPN)  Language： ENGLISH (EN)

Thesaurus term： human ,...
Semi thesaurus term： formation of a patient's condition

Register(free) or Log In to access     To see more with JDream III (charged).   {{ this.onShowAbsJLink("http://jdream3.com/lp/jglobal/index.html?docNo=17A1371034&from=J-GLOBAL&jstjournalNo=S0989A") }}

Author keywords (10)： Stevens-Johnson syndrome ,  toxic epidermal necrolysis ,  infection ,  epidemiological study ,  heterologous immunity ,  Stevens-Johnson syndrome ,  toxic epidermal necrolysis ,  infection ,  epidemiological study ,  heterologous immunity

JST classification (2)： Infectious diseases,parasitics diseases in general.  (GD01010H) ,  Immunologic diseases,allergic diseases in general.  (GD04010C)

Reference (22)：

• 1) Roujeau JC, Stern RS. Severe adverse cutaneous reactions to drugs. N. Engl. J. Med., 331, 1272-1285 (1994).
• 2) Chung WH, Wang CW, Dao RL. Severe cutaneous adverse drug reactions. J. Dermatol., 43, 758-766 (2016).
• 3) Yamane Y, Matsukura S, Watanabe Y, Yamaguchi Y, Nakamura K, Kambara T, Ikezawa Z, Aihara M. Retrospective analysis of Stevens-Johnson syndrome and toxic epidermal necrolysis in 87 Japanese patients-Treatment and outcome. Allergol. Int., 65, 74-81 (2016).
• 4) Sekula P, Dunant A, Mockenhaupt M, Naldi L, Bouwes Bavinck JN, Halevy S, Kardaun S, Sidoroff A, Liss Y, Schumacher M, Roujeau JC, RegiSCAR study group. Comprehensive survival analysis of a cohort of patients with Stevens-Johnson syndrome and toxic epidermal necrolysis. J. Invest. Dermatol., 133, 1197-1204 (2013).
• 5) Aihara M, Kano Y, Fujita H, Kambara T, Matsukura S, Katayama I, Azukizawa H, Miyachi Y, Endo Y, Asada H, Miyagawa F, Morita E, Kaneko S, Abe R, Ochiai T, Sueki H, Watanabe H, Nagao K, Aoyama Y, Sayama K, Hashimoto K, Shiohara T, SJS/TEN Study Group. Efficacy of additional i.v. immunoglobulin to steroid therapy in Stevens-Johnson syndrome and toxic epidermal necrolysis. J. Dermatol., 42, 768-777 (2015).

Terms in the title (4)： Stevens-Johnson症候群 ,  中毒性表皮壊死症 ,  病態形成 ,  感染性疾患